Artie Kavanaugh

Join Artie Kavanaugh, a rheumatologist from UC San Diego, and Quillen Connelly from Galway Clinic, as they delve into the intricate realm of psoriatic arthritis. They discuss the rising placebo response rates tied to socioeconomic factors and the urgent need for gender-specific research in treatment. Artie breaks down the potential of combination therapies, while Quillen shares insights on the durable effectiveness of bimikizumab. Together, they illuminate the latest advancements in diagnosis and treatment, providing a comprehensive overview for clinicians.

Catherine Bakewell, a seasoned rheumatologist and ultrasound expert, Philip Meese, a dedicated researcher on bimekizumab, and Artie Kavanaugh, an insightful rheumatologist reporting on ACR updates, dive into cutting-edge topics. They discuss the promising results of bimekizumab in alleviating pain and fatigue in psoriatic arthritis. Insights into the implications of weight loss drugs on treatment outcomes are explored, alongside crucial findings on sex differences affecting disease impact, driving home the need for tailored strategies in patient care.

Drs. Kavanaugh and Cush discuss topics from the EULAR 2024 Meeting, including the impact of anxiety on disease activity in RA patients, challenges in treating difficult cases of RA and psoriatic arthritis, recognizing and addressing depression symptoms, and exploring studies on ILD in RA patients. They also cover the use of AI in treatment analysis, CAR-T therapy for autoimmune diseases, and the efficacy of Dukravicitinib in managing lupus skin conditions.